1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

Core Insights - Cytek Biosciences, Inc. has received NMPA approval for its 1-laser and 2-laser 6-color TBNK reagent cocktails for clinical diagnostic use in China, marking a significant milestone for the company [1][3] Group 1: Product Approval and Market Impact - The approved TBNK reagents are designed for clinical diagnostics, enabling the identification and quantification of key lymphocyte subsets, which are crucial for assessing immune system status [2][3] - This approval enhances Cytek's market presence in China and opens new opportunities while strengthening its competitive advantage [3] Group 2: Technology and Performance - The TBNK assay is validated on the Cytek Northern Lights-Clinical (NL-CLC) cell analysis systems, ensuring optimal performance in a multicolor environment [3] - The use of an on-board volumetric meter for absolute cell counts reduces testing costs compared to traditional bead counting methods [3] Group 3: Company Overview - Cytek Biosciences is a leading cell analysis solutions company that utilizes its patented Full Spectrum Profiling™ (FSP™) technology to deliver high-resolution and high-sensitivity cell analysis [4] - The company's product suite includes core instruments like the Cytek Aurora™ and Northern Lights™ systems, as well as various reagents and software solutions [4]